Clinical experience with eplerenone to treat chronic central serous chorioretinopathy

Purpose Chronic central serous chorioretinopathy (CSC) is a vision-threatening eye disease for which there is still no approved treatment. Recent studies suggest that the corticosteroid pathway in the choroid is implicated in CSC pathogenesis, and that therapy with the aldosterone antagonist epleren...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Graefe's archive for clinical and experimental ophthalmology 2016-11, Vol.254 (11), p.2151-2157
Hauptverfasser:	Cakir, Bertan, Fischer, Franziska, Ehlken, Christoph, Bühler, Anima, Stahl, Andreas, Schlunck, Günther, Böhringer, Daniel, Agostini, Hansjürgen, Lange, Clemens
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration, Oral Adult Aged Aged, 80 and over Central Serous Chorioretinopathy - diagnosis Central Serous Chorioretinopathy - drug therapy Chronic Disease Dose-Response Relationship, Drug Female Fluorescein Angiography Follow-Up Studies Fundus Oculi Humans Male Medicine Medicine & Public Health Middle Aged Mineralocorticoid Receptor Antagonists - administration & dosage Ophthalmology Retinal Disorders Retinal Pigment Epithelium - pathology Retrospective Studies Spironolactone - administration & dosage Spironolactone - analogs & derivatives Tomography, Optical Coherence - methods Treatment Outcome Visual Acuity
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!